Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Global Blood Therapeutics
Global Blood Therapeutics
(GBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Oxbryta
Voxelotor
2019-11-25
2032-2037
Anemia
,
Sickle cell anemia
,
Hemolytic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voxelotor
renal insufficiency
,
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
hypoxia
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
chronic renal insufficiency
,
kidney diseases
,
lung diseases
,
acute lung injury
,
lung injury
,
ulcer
,
leg ulcer
,
sickle cell anemia
,
anemia
Vitamin k
malnutrition
Menatetrenone
sickle cell anemia
Retinol
central serous chorioretinopathy
,
glaucoma
,
keratoconjunctivitis sicca
,
dry eye syndromes
Carbendazim
constipation
,
ovarian neoplasms
,
ovarian epithelial carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use